PPJ Healthcare Enterprises, Inc.
PPJE · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $148 | $161 | $174 | $194 |
| % Growth | -8.1% | -7.3% | -10.4% | – |
| Cost of Goods Sold | $110 | $156 | $138 | $146 |
| Gross Profit | $38 | $5 | $35 | $47 |
| % Margin | 25.9% | 3.1% | 20.3% | 24.5% |
| R&D Expenses | $38 | $37 | $37 | $12 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $5 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $38 | $37 | $42 | $12 |
| Operating Income | $0 | -$32 | -$6 | $35 |
| % Margin | 0% | -19.9% | -3.7% | 18.3% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $0 | -$32 | -$6 | $35 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | -$32 | -$6 | $35 |
| % Margin | 0% | -19.9% | -3.7% | 18.3% |
| EPS | 0 | 0 | 0 | 0 |
| % Growth | – | – | – | – |
| EPS Diluted | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out | 8,904,886 | 9,204,483 | 8,904,886 | 5,504,836 |
| Weighted Avg Shares Out Dil | 8,904,886 | 9,204,483 | 8,904,886 | 5,504,836 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$32 | -$6 | $35 |
| % Margin | 0% | -19.9% | -3.7% | 18.3% |